Trial Details
COMPLETEDBasic Information
| Clinical ID | c994 |
|---|---|
| Identifier | NCT01612039 |
| Trial Title | Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ASP3291|DRUG: Placebo |
Participant Information
| Sponsor | Telsar Pharma Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-07-12 |
|---|---|
| Primary Completion Date | 2025-04-14 |
| Completion Date | 2025-04-14 |